Nymox Pharmaceutical
NYMX
#10797
Rank
โ‚น1.74 B
Marketcap
Country
โ‚น19.16
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

EPS for Nymox Pharmaceutical (NYMX)

EPS in 2023 (TTM): -โ‚น4.92

According to Nymox Pharmaceutical's latest financial reports the company's current EPS (TTM) is -โ‚น5.75. In 2022 the company made an earnings per share (EPS) of -โ‚น7.66 an increase over its 2021 EPS that were of -โ‚น14.37.

EPS history for Nymox Pharmaceutical from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น4.92-35.81%
2022-โ‚น7.66-46.67%
2021-โ‚น14.37-11.76%
2020-โ‚น16.28-15%
2019-โ‚น19.165.26%
2018-โ‚น18.20-26.92%
2017-โ‚น24.90-7.14%
2016-โ‚น26.82-40.43%
2015-โ‚น45.02291.67%
2014-โ‚น11.49-7.69%
2013-โ‚น12.45-43.48%
2012-โ‚น22.03-25.81%
2011-โ‚น29.6955%
2010-โ‚น19.1625%
2009-โ‚น15.330.08%
2008-โ‚น15.31-11.12%
2007-โ‚น17.23-0.16%
2006-โ‚น17.2628.59%
2005-โ‚น13.42-12.49%
2004-โ‚น15.34-16.05%
2003-โ‚น18.2719.07%
2002-โ‚น15.3414.45%
2001-โ‚น13.41-22.16%
2000-โ‚น17.225.64%
1999-โ‚น16.30-34.59%
1998-โ‚น24.92-3.6%
1997-โ‚น25.86

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น836.68-14,657.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น125.48-2,283.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น345.66-6,114.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,704-47,142.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น878.37-15,383.33%๐Ÿ‡บ๐Ÿ‡ธ USA